365betÌåÓýÔÚÏßÊÀ½ç±­

Skip to main content
You have permission to edit this article.
Edit

Ozempic's double-sided coin: Amid skyrocketing popularity of GLP-1 drugs, a burgeoning lawsuit looms

US-NEWS-OZEMPIC-LAWSUIT-GET

The diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023, in Los Angeles. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes, who risk serious health consequences without medication. The FDA has approved its use under the name Wegovy for weight management.

Kayce Zangaro couldn't stop throwing up.

She had been taking Ozempic for a few months, starting in June 2023, with the goal of losing weight. Symptom-free at first, she lost 30 pounds. But when she increased her dose, the nausea began � followed by nonstop vomiting.





Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News

Breaking News (FlagLive!)